Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
Public ClinicalTrials.gov record NCT02512042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicentre, Double Blind, Active Controlled, Parallel Group, Two Arm, Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension (Manufactured by Indoco Remedies Ltd. for Watson Pharma Pvt Ltd.), to Brinzolamide (Azopt®) 1% Ophthalmic Suspension of Alcon Laboratories, Inc., In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
Study identification
- NCT ID
- NCT02512042
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Actavis Inc.
- Industry
- Enrollment
- 973 participants
Conditions and interventions
Conditions
Interventions
- Test-Brinzolamide 1% Ophthalmic suspension Drug
- Reference-Brinzolamide 1% Ophthalmic suspension Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2015
- Primary completion
- Mar 31, 2016
- Completion
- Apr 30, 2016
- Last update posted
- Mar 1, 2020
2015 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| David Wirta, MD | Newport Beach | California | 92663 | — |
| Shettle Eye Research, Inc. | Largo | Florida | 33773 | — |
| AMB Research Center, Inc. | Miami | Florida | 33144 | — |
| Eye Care Centers Management, Inc. | Morrow | Georgia | 30260 | — |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | — |
| Heart of America Eye Care PA | Shawnee Mission | Kansas | 66204 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| Las Vegas Physicians Research Group | Henderson | Nevada | 89074 | — |
| Keystone Research Ltd. | Austin | Texas | 78731 | — |
| Keystone Research Ltd. | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02512042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2020 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02512042 live on ClinicalTrials.gov.